Literature DB >> 28210836

Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.

Ying M Tang1, Christian D Stone2.   

Abstract

The problem of Clostridium difficile infection (CDI) has reached epidemic proportions, particularly in industrialized nations. The pathophysiology, disease course and the potential complications are well appreciated in the general hospitalized patient. However, when CDI occurs in the setting of inflammatory bowel disease (IBD), a number of distinct differences in the diagnosis and clinical management of the infection in this population should be appreciated by gastroenterologists, hospitalists and other care providers. This review highlights the unique aspects of CDI when it occurs in IBD patients with an emphasis on the challenge of distinguishing persistent infection from exacerbation of underlying chronic colitis. An understanding of how CDI may differ in presentation and how management should be altered can prevent serious and life-threatening complications.

Entities:  

Keywords:  Clostridium difficile infection; Crohn’s disease; Inflammatory bowel disease; Treatment; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28210836     DOI: 10.1007/s12328-017-0719-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  58 in total

1.  "Diversion" colitis caused by Clostridium difficile infection: report of a case.

Authors:  Effie Tsironi; Peter M Irving; Roger M Feakins; David S Rampton
Journal:  Dis Colon Rectum       Date:  2006-07       Impact factor: 4.585

Review 2.  Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Authors:  Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun
Journal:  Am J Gastroenterol       Date:  2013-02-26       Impact factor: 10.864

3.  Effect of treatment variation on outcomes in patients with Clostridium difficile.

Authors:  Adam T Brown; Charles F Seifert
Journal:  Am J Med       Date:  2014-05-23       Impact factor: 4.965

4.  Similar outcomes of IBD inpatients with Clostridium difficile infection detected by ELISA or PCR assay.

Authors:  Yinghong Wang; Ashish Atreja; Xianrui Wu; Bret A Lashner; Aaron Brzezinski; Bo Shen
Journal:  Dig Dis Sci       Date:  2013-03-24       Impact factor: 3.199

5.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

6.  The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.

Authors:  Evelyn M Clayton; Mary C Rea; Fergus Shanahan; Eamonn M M Quigley; Barry Kiely; Colin Hill; R Paul Ross
Journal:  Am J Gastroenterol       Date:  2009-03-24       Impact factor: 10.864

7.  Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

Authors:  Daniela Jodorkovsky; Yuki Young; Maria T Abreu
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

8.  Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Authors:  Y C Manabe; J M Vinetz; R D Moore; C Merz; P Charache; J G Bartlett
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391

9.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

10.  Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.

Authors:  Preeta K Kutty; Christopher W Woods; Arlene C Sena; Stephen R Benoit; Susanna Naggie; Joyce Frederick; Sharon Evans; Jeffery Engel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

View more
  6 in total

1.  Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease.

Authors:  Elissa Lin; Kevin Lin; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-11

2.  Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.

Authors:  Masoumeh Azimirad; Sara Mohammad Ali Gol; Ehsan Javanmard; Hamed Mirjalali; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Shabnam Shahrokh; Hedieh Balaii; Amir Sadeghi; Mohammad Reza Zali
Journal:  Turk J Gastroenterol       Date:  2021-06       Impact factor: 1.852

3.  Association Between Immunosuppressive Therapy and Outcome of Clostridioides difficile Infection: Systematic Review and Meta-Analysis.

Authors:  Yiting Li; Haifeng Cai; Daniel A Sussman; Jean Donet; Kevin Dholaria; Jiajia Yang; Ami Panara; Ryan Croteau; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2021-09-23       Impact factor: 3.487

Review 4.  Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.

Authors:  Sai-Long Zhang; Shu-Na Wang; Chao-Yu Miao
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

Review 5.  Antibiotic treatment of acute gastroenteritis in children.

Authors:  Eugenia Bruzzese; Antonietta Giannattasio; Alfredo Guarino
Journal:  F1000Res       Date:  2018-02-15

6.  Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis.

Authors:  Nitsan Maharshak; Idan Barzilay; Hasya Zinger; Keren Hod; Iris Dotan
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.